Literature DB >> 30815871

Innovative approaches to enhancing maternal and newborn survival: Indonesia's experience in an era of global commitments to reducing mortality.

Koki Agarwal1, Katherine Lilly1, Jeffrey Smith1.   

Abstract

Globally, countries have made impressive strides toward achieving targets set by the Millennium Development Goals (MDGs) to reduce maternal mortality. The subsequent Sustainable Development Goals (SDGs) have further challenged countries to accelerate these reductions. While Indonesia invested in several initiatives to improve care for mothers and newborns and made large gains in improving skilled care at birth, the country fell short of its MDG target. This paper outlines some of the remaining challenges and highlights the role of the US Agency for International Development-funded Expanding Maternal and Neonatal Survival (EMAS) program in eliminating the barriers to improved care. Achieving the SDGs by 2030 will require strong cross-sectoral collaboration and innovative approaches, such as the recent launch of Indonesia's national health insurance program, which can accelerate reductions in mortality by reaching women most in need of services.
© 2019 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Expanding Maternal and Neonatal Survival (EMAS); Indonesia; Maternal and neonatal mortality; Millennium Development Goals (MDGs); Skilled birth attendants

Mesh:

Year:  2019        PMID: 30815871     DOI: 10.1002/ijgo.12729

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Effect of a community based social marketing strategy on the uptake of clean delivery kits in peri-urban communities of Karachi, Pakistan.

Authors:  Asra Usmani; Shazia Sultana; Imran Nisar; Shehla Zaidi; Imtiaz Jehan; Anita Zaidi
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-28       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.